SCHEMBL160565

SCHEMBL160565

O=C(O)c1ccccc1-c1cccc(-c2ccccc2C(=O)O)c1-c1ccccc1C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.68
ALDH1A1 P00352 5/20 0.62
LMNA P02545 2/20 0.62
MAPT P10636 1/20 0.62
HNF4A P41235 1/20 0.59
L3MBTL1 Q9Y468 2/20 0.57
ALOX15 P16050 1/20 0.56
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX12 P18054 1/20 0.55
HSD17B10 Q99714 1/20 0.52
GAA P10253 1/20 0.52
FOLH1 Q04609 2/20 0.51
SOS1 Q07889 1/20 0.49
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
KDM4E B2RXH2 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31540338 1.00 MYC (0.68) MYCALDH1A1LMNAMAPTHNF4A
SCHEMBL5089936 0.93 ALDH1A1 (0.66) MYCALDH1A1LMNAMAPTHNF4A
SCHEMBL11217790 0.88 MYC (0.69) MYCALDH1A1LMNAMAPTHNF4A
SCHEMBL36145 0.88 ALDH1A1 (0.72) MYCALDH1A1LMNAMAPTHNF4A
SCHEMBL30028907 0.88 ALDH1A1 (0.72) MYCALDH1A1LMNAMAPTHNF4A
SCHEMBL7564271 0.88 MYC (0.59) MYCALDH1A1LMNAMAPTHNF4A
Hydrochloric Acid SCHEMBL10888462 0.85 ALDH1A1 (0.68) MYCALDH1A1LMNAMAPTHNF4A
SCHEMBL2830888 0.85 ALDH1A1 (0.68) MYCALDH1A1LMNAMAPTHNF4A
Hydrochloric Acid SCHEMBL1681943 0.85 ALDH1A1 (0.68) MYCALDH1A1LMNAMAPTHNF4A
Hydrochloric Acid SCHEMBL7579852 0.85 ALDH1A1 (0.68) MYCALDH1A1LMNAMAPTHNF4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354659-A1 SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION NUOVO PIGNONE TECNOLOGIE – S R L (IT) 2025-11-20 US claimed
WO-2025238576-A1 SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION Nuovo Pignone Tecnologie – S.r.l. (IT) 2025-11-20 WO claimed
US-12397489-B2 Methods of making metal-organic framework extrudates ExxonMobil Technology and Engineering Company (US) 2025-08-26 US claimed
US-20240261758-A1 Spherical Metal-Organic Frameworks Using Alginate ExxonMobil Technology and Engineering Company 2024-08-08 US claimed
US-20240247002-A1 Flocculation and Rapid Filtration Of Metal Organic Frameworks ExxonMobil Technology and Engineering Company 2024-07-25 US claimed
EP-4347114-A1 SPHERICAL METAL-ORGANIC FRAMEWORKS USING ALGINATE ExxonMobil Technology and Engineering Company (US) 2024-04-10 EP claimed
EP-4340987-A1 FLOCCULATION AND RAPID FILTRATION OF METAL ORGANIC FRAMEWORKS ExxonMobil Technology and Engineering Company (US) 2024-03-27 EP claimed
EP-4114564-A1 METHODS OF MAKING METAL-ORGANIC FRAMEWORK COMPOSITES ExxonMobil Technology and Engineering Company (US) 2023-01-11 EP claimed
US-20230001617-A1 Methods of Making Metal-Organic Framework Extrudates EXXONMOBIL RES & ENG CO (US) 2023-01-05 US claimed
US-20220410121-A1 Metal-Organic Material Extrudates, Methods of Making, and Methods of Use EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2022-12-29 US claimed
US-20170008915-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-01-12 US claimed
EP-3074404-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS The Regents of The University of California (US) 2016-10-05 EP claimed
US-20160221920-A1 PROCESS FOR THE RECOVERY OF COMPONENTS FORMING A METAL-ORGANIC FRAMEWORK MATERIAL BASF SE (DE) 2016-08-04 US claimed
WO-2015127033-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-08-27 WO claimed
US-20140311507-A1 Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-10-23 US claimed
EP-2739169-A2 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS Massachusetts Institute Of Technology (US) 2014-06-11 EP claimed
WO-2013019865-A2 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-02-07 WO claimed
EP-2502671-A2 CRYSTALLINE POROUS ORGANIC-INORGANIC HYBRID MATERIAL AND A PRODUCTION METHOD THEREFOR Korea Research Institute Of Chemical Technology (KR) 2012-09-26 EP claimed
US-8252950-B2 Porous organic-inorganic hybrid materials with crystallinity and method for preparing thereof Kora Research Institute of Chemical Technology (KR) 2012-08-28 US claimed
US-20110118490-A1 Porous Organic-Inorganic Hybrid Materials with Crystallinity and Method for Preparing Thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KP) 2011-05-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118490-A1 Porous Organic-Inorganic Hybrid Materials with Crystallinity and Method for Preparing Thereof ATM, TPR, BMP2 MYC 1920/4885ALDH1A1 4560/4885LMNA 2868/4885
US-20170008915-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS HAO2, ASF1A, FTO MYC 414/4885ALDH1A1 639/4885LMNA 4321/4885
US-20240247002-A1 Flocculation and Rapid Filtration Of Metal Organic Frameworks FLOT1, HNRNPF, POF1B MYC 2120/4885ALDH1A1 2671/4885LMNA 3914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.